Medivation Inc (MDVN) Soars On Pfizer Bid
Big pharma merger today and no it does not involve Valeant - those days are over - at least for now. Medivation Inc (NASDAQ: MDVN) is soaring around 20 percent as Pfizer Inc. (NYSE:PFE) has bid $14 billion for the company. The merger widely speculated over the weekend was announced this morning. So just how much synergies are we talking about? Here is what the sell side is saying.
This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here
If you are subscribed and having an account error please clear cache and then cookies if that does not work email firstname.lastname@example.org and we will get back to you as quick as humanly possible